Cinhyaluronate sodium
Highest phase reached
Phase 3
Drug type
Unknown
- Listing at source
- Listed
- Highest phase reached
- Phase 3
- Drug type
- Unknown
- Drug name
- Cinhyaluronate sodium
- cinhialuronato de sodio
- Cinhialuronato de sodio
- cinhyaluronate de sodium
- Cinhyaluronate de sodium
- cinhyaluronate sodium
- Cinhyaluronate sodium
- cinhyaluronate sodium [INN]
- CINHYALURONATE SODIUM [USAN]
- Cinhyaluronate sodium [WHO-DD]
- cinhyaluronate sodium inn
- cinhyaluronate sodium usan
- cinhyaluronate sodium who dd
- s1226 12
- S1226(12%)
- si 614
- Si-614
- SI-614
- SODIUM SALT OF HYALURONIC ACID PARTLY (12%) AMIDIFIED WITH 3-((3-PHENYLPROP-2-ENOYL)OXY)PROPAN-1-AMINE
- sodium salt of hyaluronic acid partly 12 amidified with 3 3 phenylprop 2 enoyl oxy propan 1 amine
- CAS registry numbers
- 1372784-20-7
- ChEMBL ID
- CHEMBL4298103
- FDA ingredient codes (UNII)
- Q832TKH849
- First in class
- No
- Orphan designation
- No
Investigated indications
- Condition
- Dry Eye Syndromes
- Highest recorded phase
- 3
- Condition identifier
- EFO:1000906
- Subject identifier
- D015352
- Condition identifier
- HP_0001097
- Highest recorded phase
- 3
- Condition identifier
- MONDO_0004975
- Condition identifier
- MONDO_0004975
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0006733
- Highest recorded phase
- 3
- NCT01558999
- NCT02205840
- NCT05411367
- Prodrug
- No
- Inorganic
- No
- Natural product
- No
Related records
Trials (13)
- A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
- A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
- A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals
- A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients
- A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
- Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
- Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma
- Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma
- Efficacy of Fixed-doses of Antihypertensive and Statin Drugs
- Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease
- Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.
- Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.
- Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002)
In development for (1)
- Dry eye syndrome Phase 3